drugset / Trial / NCT05758428
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Nebulized Ensifentrine in Healthy Chinese Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a phase 1, open-label, parallel cohort study to evaluate the PK, safety and tolerability of nebulized ensifentrine following administration of single and multiple doses in healthy Chinese male subjects.
Timeline
- Start
- 2023-03-06
- Primary completion
- 2023-04-18
- Completion
- 2023-04-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ensifentrine | Unknown | 1.5 mg | Other |
| Subject | Ensifentrine | Unknown | 3 mg | Other |
| Subject | Ensifentrine | Unknown | 6 mg | Other |